Terazosin (Terazosin Hydrochloride Hydrate)

Adult dose

1. Urinary disorders caused by benign prostatic hyperplasia - Initial dose: Administer 1 mg orally at bedtime as an initial dose of Terazosin hydrochloride, and this dose should not be exceeded. - Maintenance dose: Gradually increase the dose until improvement of symptoms, administering 5-10 mg orally once a day. 2. Hypertension - Initial dose: Administer 1 mg orally at bedtime as an initial dose of Terazosin hydrochloride, and this dose should not be exceeded. - Maintenance dose:

This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to this medication or similar acting drugs, children under the age of 12, and those with genetic disorders that prevent lactose digestion. Patients with severely impaired liver or kidney function, as well as those with conditions such as orthostatic hypotension, heart disease, diabetes, or hypersensitivity should use this medication with caution. Dizziness or fainting may occur when taking this medication, so particular care should be taken when starting treatment or suddenly increasing the dose. If fainting or severe dizziness occurs, it is essential to lie down and rest immediately, and seek medical treatment if necessary. Additionally, since this medication lowers blood pressure, caution is advised when performing hazardous tasks such as working at heights or driving. While this medication aids in alleviating symptoms of benign prostatic hyperplasia, if symptoms do not improve, other treatment options should be considered. Symptoms may be similar to prostate cancer, so it is crucial to confirm the absence of cancer before treatment. Patients undergoing cataract surgery should inform their doctor about taking this medication, as special precautions may be needed during surgery. Women who are pregnant or may become pregnant should carefully weigh the risks and benefits of taking this medication, and nursing mothers should avoid taking it or stop nursing if possible. The safety and efficacy of this medication have not been established in children, so it is advisable not to use it in this population. Elderly patients should start with a low dose to prevent excessively low blood pressure and should be monitored closely during treatment. Overdosing on this medication can result in a sudden drop in blood pressure, so in such cases, immediate medical attention is required. Finally, this medication should be stored out of reach of children, and it should not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral or ocular mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory abnormalities with cough and fever, jaundice (yellowing of the skin or eyes), extreme fatigue, sudden and severe headache, lightning headache, seizures, confusion of consciousness, vision abnormalities, paralysis, urinary incontinence

Mild side effects

• Dizziness
• fatigue
• peripheral edema
• depression
• irritability
• headache
• lethargy
• weakness
• sweating
• insomnia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best kept at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness over time.

Appearance

Pale orange round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle